Notably, a recent study showed that SLAMF7 expression on target cells and binding to SLAMF7 on phagocytes mediated by coupling to Mac-1 are critical for the elimination of tumor cells by phagocytosis in CD47-blocking therapy [54]. Here, SLAMF7 is linked to neoplasm.